| HGNC Family | Ion channels |
| Name | sodium channel, voltage gated, type IX alpha subunit |
| Description | This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSCN9A encodes the pore‐forming α‐subunit of the voltage‐gated sodium channel Nav1.7, a molecular “gatekeeper” that amplifies small subthreshold depolarizations in peripheral nociceptive and sympathetic neurons. In both humans and animal models, Nav1.7 plays an essential, nonredundant role in pain detection—its normal channel activity is required to allow neuronal firing in response to noxious stimuli, and structural studies have begun to delineate the atomic basis of its gating properties. Moreover, naturally occurring variants—including specific coding single nucleotide polymorphisms that subtly alter channel biophysics—are shown to modulate patients’ pain thresholds."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic alterations in SCN9A can lead to dramatic, clinically recognizable phenotypes. Loss‐of‐function mutations result in congenital insensitivity to pain (often accompanied by anosmia), owing to a complete abrogation of Nav1.7 activity in nociceptive neurons. In contrast, gain‐of‐function mutations—with shifts in activation to more hyperpolarized potentials, impaired inactivation, or enhanced persistent and ramp currents—render sensory neurons hyperexcitable and underlie several painful neuropathies, such as primary erythermalgia (erythromelalgia), paroxysmal extreme pain disorder, and painful small fiber neuropathy. Additionally, some SCN9A variants may subtly predispose individuals to heightened pain responses or even contribute to other neurological phenotypes such as febrile seizures, thereby highlighting the spectrum of channelopathies linked to Nav1.7 dysfunction."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdvanced biophysical investigations and translational studies have further illuminated Nav1.7 as a prime therapeutic target. High‐resolution structural analyses and electrophysiological studies using mutant channels have provided insight into altered gating mechanisms that underlie hyperexcitability, while pharmacological studies—including those using selective peptides from centipede venom and analyses of local anesthetic efficacy—demonstrate that targeting Nav1.7 could yield potent analgesia. In addition, aberrant Nav1.7 expression has been implicated in non‐pain conditions such as cancer metastasis, and emerging data indicate that Nav1.7 activity can influence gene expression pathways (for example, opioid peptide regulation), thereby expanding its potential impact on neuronal signaling. Finally, intricate mechanisms regulating Nav1.7 trafficking—including post‐translational modifications via SUMOylation—highlight additional layers of functional control that may be exploited for improved pain therapeutics."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "James J Cox, Frank Reimann, Adeline K Nicholas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An SCN9A channelopathy causes congenital inability to experience pain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature05413"}], "href": "https://doi.org/10.1038/nature05413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17167479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17167479"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sulayman D Dib-Hajj, Yang Yang, Joel A Black, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Na(V)1.7 sodium channel: from molecule to man."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Rev Neurosci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nrn3404"}], "href": "https://doi.org/10.1038/nrn3404"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23232607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23232607"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Joost P H Drenth, Stephen G Waxman "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI33297"}], "href": "https://doi.org/10.1172/JCI33297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18060017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18060017"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Frank Reimann, James J Cox, Inna Belfer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pain perception is altered by a nucleotide polymorphism in SCN9A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0913181107"}], "href": "https://doi.org/10.1073/pnas.0913181107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20212137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20212137"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jan Weiss, Martina Pyrski, Eric Jacobi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss-of-function mutations in sodium channel Nav1.7 cause anosmia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature09975"}], "href": "https://doi.org/10.1038/nature09975"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21441906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21441906"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Y Yang, Y Wang, S Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2003.012153"}], "href": "https://doi.org/10.1136/jmg.2003.012153"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14985375"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14985375"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Catharina G Faber, Janneke G J Hoeijmakers, Hye-Sook Ahn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.22485"}], "href": "https://doi.org/10.1002/ana.22485"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21698661"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21698661"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Y P Goldberg, J MacFarlane, M L MacDonald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-0004.2007.00790.x"}], "href": "https://doi.org/10.1111/j.1399-0004.2007.00790.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17470132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17470132"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Theodore R Cummins, Sulayman D Dib-Hajj, Stephen G Waxman "}, {"type": "b", "children": [{"type": "t", "text": "Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.2695-04.2004"}], "href": "https://doi.org/10.1523/JNEUROSCI.2695-04.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15385606"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15385606"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Sulayman D Dib-Hajj, Theodore R Cummins, Joel A Black, et al. "}, {"type": "b", "children": [{"type": "t", "text": "From genes to pain: Na v 1.7 and human pain disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Trends Neurosci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.tins.2007.08.004"}], "href": "https://doi.org/10.1016/j.tins.2007.08.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17950472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17950472"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Nanda A Singh, Chris Pappas, E Jill Dahle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1000649"}], "href": "https://doi.org/10.1371/journal.pgen.1000649"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19763161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19763161"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Sultan Ahmad, Leif Dahllund, Anders B Eriksson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A stop codon mutation in SCN9A causes lack of pain sensation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddm160"}], "href": "https://doi.org/10.1093/hmg/ddm160"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17597096"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17597096"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Chongyang Han, Anthony M Rush, Sulayman D Dib-Hajj, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.20776"}], "href": "https://doi.org/10.1002/ana.20776"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16392115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16392115"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Patrick L Sheets, James O Jackson, Stephen G Waxman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2006.127027"}], "href": "https://doi.org/10.1113/jphysiol.2006.127027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17430993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17430993"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Joost P H Drenth, Rene H M te Morsche, Gerard Guillet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.0022-202X.2005.23737.x"}], "href": "https://doi.org/10.1111/j.0022-202X.2005.23737.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15955112"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15955112"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "M Estacion, S D Dib-Hajj, P J Benke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.3443-08.2008"}], "href": "https://doi.org/10.1523/JNEUROSCI.3443-08.2008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18945915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18945915"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Huaizong Shen, Dongliang Liu, Kun Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structures of human Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "v"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.7 channel in complex with auxiliary subunits and animal toxins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aaw2493"}], "href": "https://doi.org/10.1126/science.aaw2493"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30765606"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30765606"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Shilong Yang, Yao Xiao, Di Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1306285110"}], "href": "https://doi.org/10.1073/pnas.1306285110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24082113"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24082113"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Michael S Minett, Vanessa Pereira, Shafaq Sikandar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms9967"}], "href": "https://doi.org/10.1038/ncomms9967"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26634308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26634308"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lucy A McDermott, Greg A Weir, Andreas C Themistocleous, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Defining the Functional Role of Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "V"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.7 in Human Nociception."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2019.01.047"}], "href": "https://doi.org/10.1016/j.neuron.2019.01.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30795902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30795902"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "J K J Diss, D Stewart, F Pani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate Cancer Prostatic Dis (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.pcan.4500796"}], "href": "https://doi.org/10.1038/sj.pcan.4500796"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16088330"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16088330"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "T Patrick Harty, Sulayman D Dib-Hajj, Lynda Tyrrell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.3424-06.2006"}], "href": "https://doi.org/10.1523/JNEUROSCI.3424-06.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17135418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17135418"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Tanya Z Fischer, Elaine S Gilmore, Mark Estacion, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.21678"}], "href": "https://doi.org/10.1002/ana.21678"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19557861"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19557861"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Brian W Jarecki, Andrew D Piekarz, James O Jackson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI40801"}], "href": "https://doi.org/10.1172/JCI40801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20038812"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20038812"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jonathan W Theile, Brian W Jarecki, Andrew D Piekarz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navbeta4 peptide-mediated resurgent sodium currents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2010.200915"}], "href": "https://doi.org/10.1113/jphysiol.2010.200915"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21115638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21115638"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Sulayman D Dib-Hajj, Mark Estacion, Brian W Jarecki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pain (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1744-8069-4-37"}], "href": "https://doi.org/10.1186/1744-8069-4-37"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18803825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18803825"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Iulia Blesneac, Andreas C Themistocleous, Carl Fratter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pain (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/j.pain.0000000000001116"}], "href": "https://doi.org/10.1097/j.pain.0000000000001116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29176367"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29176367"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Erik T Dustrude, Aubin Moutal, Xiaofang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hierarchical CRMP2 posttranslational modifications control NaV1.7 function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1610531113"}], "href": "https://doi.org/10.1073/pnas.1610531113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27940916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27940916"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Erik T Dustrude, Sarah M Wilson, Weina Ju, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.474924"}], "href": "https://doi.org/10.1074/jbc.M113.474924"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23836888"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23836888"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xiaoyang Cheng, Sulayman D Dib-Hajj, Lynda Tyrrell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pain (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1744-8069-4-1"}], "href": "https://doi.org/10.1186/1744-8069-4-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18171466"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18171466"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yang Yang, Sulayman D Dib-Hajj, Jian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Na(V)1.7 mutant channel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms2184"}], "href": "https://doi.org/10.1038/ncomms2184"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23149731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23149731"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Gilberto Vargas-Alarcon, Edith Alvarez-Leon, Jose-Manuel Fragoso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Musculoskelet Disord (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2474-13-23"}], "href": "https://doi.org/10.1186/1471-2474-13-23"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22348792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22348792"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Tanya Z Fischer, Stephen G Waxman "}, {"type": "b", "children": [{"type": "t", "text": "Familial pain syndromes from mutations of the NaV1.7 sodium channel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann N Y Acad Sci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1749-6632.2009.05110.x"}], "href": "https://doi.org/10.1111/j.1749-6632.2009.05110.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20146699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20146699"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Janneke G J Hoeijmakers, Chongyang Han, Ingemar S J Merkies, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awr349"}], "href": "https://doi.org/10.1093/brain/awr349"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22286749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22286749"}]}]}]}
|
| Synonyms | GEFSP7, FEB3B, NENA, NAV1.7, SFNP, HSAN2D, NE-NA, ETHA |
| Proteins | SCN9A_HUMAN |
| NCBI Gene ID | 6335 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SCN9A has 8,195 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 129 datasets.
Click the + buttons to view associations for SCN9A from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SCN9A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SCN9A gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SCN9A gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SCN9A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SCN9A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SCN9A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SCN9A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SCN9A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SCN9A gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SCN9A gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCN9A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SCN9A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SCN9A gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCN9A gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SCN9A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SCN9A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with SCN9A gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SCN9A gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SCN9A gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SCN9A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SCN9A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SCN9A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SCN9A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SCN9A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCN9A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SCN9A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SCN9A gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SCN9A gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SCN9A gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SCN9A gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for SCN9A protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving SCN9A gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving SCN9A gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with SCN9A gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SCN9A gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SCN9A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SCN9A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SCN9A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SCN9A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for SCN9A protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SCN9A gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCN9A gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SCN9A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SCN9A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SCN9A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SCN9A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SCN9A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SCN9A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SCN9A from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SCN9A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SCN9A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SCN9A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SCN9A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SCN9A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SCN9A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SCN9A gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SCN9A gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SCN9A gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SCN9A protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SCN9A protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SCN9A protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SCN9A gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SCN9A gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SCN9A gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SCN9A gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SCN9A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SCN9A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SCN9A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SCN9A gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding SCN9A receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with SCN9A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SCN9A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SCN9A gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SCN9A gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SCN9A gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SCN9A protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SCN9A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SCN9A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SCN9A protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SCN9A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with SCN9A gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with SCN9A gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with SCN9A gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with SCN9A gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SCN9A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SCN9A protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SCN9A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SCN9A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SCN9A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving SCN9A protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate SCN9A protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCN9A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SCN9A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SCN9A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SCN9A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SCN9A protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SCN9A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SCN9A gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SCN9A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SCN9A gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SCN9A gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NURSA Protein Complexes | protein complexs containing SCN9A protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SCN9A gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SCN9A from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SCN9A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SCN9A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SCN9A protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SCN9A protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving SCN9A protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SCN9A protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SCN9A gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SCN9A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SCN9A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SCN9A gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SCN9A gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SCN9A gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SCN9A gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SCN9A gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SCN9A gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SCN9A gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SCN9A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SCN9A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SCN9A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SCN9A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SCN9A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SCN9A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SCN9A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SCN9A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SCN9A protein from the WikiPathways Pathways 2024 dataset. | |